David Moller
Geen lopende functies
Profiel
David E.
Moller formerly worked at Eli Lilly & Co., as Vice President-Endocrine & Cardiovascular Research, Merck & Co., Inc., as Vice President-Metabolic Disorders, Poxel SA, as Chief Scientific Officer & Executive VP, Harvard Medical School, as Assistant Professor, and Sigilon Therapeutics, Inc., as Chief Scientific Officer.
Dr. Moller received his undergraduate degree from Brown University and doctorate degree from the University of Cincinnati (Ohio).
Eerdere bekende functies van David Moller
| Bedrijven | Functie | Einde |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| SIGILON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
| POXEL | Chief Tech/Sci/R&D Officer | - |
Opleiding van David Moller
| Brown University | Undergraduate Degree |
| University of Cincinnati (Ohio) | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| POXEL | Health Technology |
| SIGILON THERAPEUTICS, INC. | Health Technology |
